Search

A tandem structure was invented to enhance photon utilization efficiency and reduce thermal loss. Considering the unique advantages of non-fullerene acceptors (NFAs), the combination of NFAs and the tandem concept shows great potential for organic photovoltaics (OPVs). Herein, a simple strategy to balance the voltage-current trade-off in tandem OPVs by employing mixed NFAs in rear sub-cells is reported. The V OC and J SC of rear sub-cells can be tuned by using the blend of donor/NFA/NFA. This strategy offers an easy approach to balance the V OC and J SC in tandem OPVs toward higher power conversion efficiency (PCE) without rational and careful synthesis of new materials. Tandem OPVs based on mixed NFAs in rear sub-cells exhibited the best PCE of 13.3% in the lab. Importantly, the tandem devices were certified by the National Renewable Energy Laboratory (NREL) under asymptotic scans, and a PCE of 11.52% was achieved and recognized on the most recent NREL chart. Organic photovoltaics (OPVs) have attracted considerable attention in the last decade due to some potential advantages, such as flexibility, light weight, possible semi-transparency, and fast large-area fabrication with low energy consumption. To achieve higher performing OPVs, a tandem structure was invented by stacking two or more sub-cells together. In tandem OPVs, the photon utilization efficiency can be improved and the thermal losses can be reduced. Herein, a simple strategy to balance the voltage-current trade-off in tandem OPVs by employing mixed non-fullerene acceptors in rear sub-cells is reported. By this strategy, tandem OPVs exhibited the best power conversion efficiency (PCE) of 13.3% in the lab. Importantly, the tandem devices were certified by the National Renewable Energy Laboratory (NREL) under the new protocols (asymptotic scans), and a PCE of 11.52% was achieved and recognized on the most recent NREL chart. A simple strategy to balance the voltage-current trade-off in tandem organic photovoltaics by employing mixed non-fullerene acceptors in rear sub-cells is reported. The tandem device with the best power conversion efficiency (PCE) of 13.3% was achieved in the lab. Importantly, the tandem devices were certified by the National Renewable Energy Laboratory (NREL) under the new protocols (asymptotic scans, which are much tougher than regular fast scans); a PCE of 11.52% was achieved and recognized on the most recent NREL chart.

Incorporating narrow-bandgap near-infrared absorbers as the third component in a donor/acceptor binary blend is a new strategy to improve the power conversion efficiency (PCE) of organic photovoltaics (OPV). However, there are two main restrictions: potential charge recombination in the narrow-gap material and miscompatibility between each component. The optimized design is to employ a third component (structurally similar to the donor or acceptor) with a lowest unoccupied molecular orbital (LUMO) energy level similar to the acceptor and a highest occupied molecular orbital (HOMO) energy level similar to the donor. In this design, enhanced absorption of the active layer and enhanced charge transfer can be realized without breaking the optimized morphology of the active layer. Herein, in order to realize this design, two new narrow-bandgap nonfullerene acceptors with suitable energy levels and chemical structures are designed, synthesized, and employed as the third component in the donor/acceptor binary blend, which boosts the PCE of OPV to 11.6%.

Introduction: Meconium aspiration syndrome (MAS) may cause severe pulmonary and neurologic injuries in affected infants after birth, leading to long-term adverse pulmonary or neurodevelopmental outcomes. Methods: This retrospective population-based cohort study enrolled 1,554,069 mother-child pairs between 2004 and 2014. A total of 8,049 infants were in the MAS-affected group, whereas 1,546,020 were in the healthy control group. Children were followed up for at least 3 years. According to respiratory support, MAS was classified as mild, moderate, and severe. With the healthy control group as the reference, the associations between MAS severity and adverse pulmonary outcomes (hospital admission, intensive care unit (ICU) admission, length of hospital stay, or invasive ventilator support during admission related to pulmonary problem) or adverse neurodevelopmental outcomes (cerebral palsy, needs for rehabilitation, visual impairment, or hearing impairment) were accessed. Results: MAS-affected infants had a higher risk of hospital and ICU admission and longer length of hospital stay, regardless of severity. Infants with severe MAS had a higher risk of invasive ventilator support during re-admission (odds ratio: 17.50, 95% confidence interval [CI]: 7.70–39.75, p < 0.001). Moderate (hazard ratio [HR]: 1.66, 95% CI: 1.30–2.13, p < 0.001) and severe (HR: 4.94, 95% CI: 4.94–7.11, p < 0.001) MAS groups had a higher risk of adverse neurodevelopmental outcome, and the statistical significance remained remarkable in severe MAS group after adjusting for covariates (adjusted HR: 2.28, 95% CI: 1.54–3.38, p < 0.001) Conclusions: Adverse pulmonary or neurodevelopmental outcomes could occur in MAS-affected infants at birth. Close monitoring and follow-up of MAS-affected infants are warranted. [ABSTRACT FROM AUTHOR]

Abstract Background The Taiwan Human Disease iPSC Service Consortium was established to accelerate Taiwan’s growing stem cell research initiatives and provide a platform for researchers interested in utilizing induced pluripotent stem cell (iPSC) technology. The consortium has generated and characterized 83 iPSC lines: 11 normal and 72 disease iPSC lines covering 21 different diseases, several of which are of high incidence in Taiwan. Whether there are any reprogramming-induced recurrent copy number variant (CNV) hotspots in iPSCs is still largely unknown. Methods We performed genome-wide copy number variant screening of 83 Han Taiwanese iPSC lines and compared them with 1093 control subjects using an Affymetrix genome-wide human SNP array. Results In the iPSCs, we identified ten specific CNV loci and seven “polymorphic” CNV regions that are associated with the reprogramming process. Additionally, we established several differentiation protocols for our iPSC lines. We demonstrated that our iPSC-derived cardiomyocytes respond to pharmacological agents and were successfully engrafted into the mouse myocardium demonstrating their potential application in cell therapy. Conclusions The CNV hotspots induced by cell reprogramming have successfully been identified in the current study. This finding may be used as a reference index for evaluating iPSC quality for future clinical applications. Our aim was to establish a national iPSC resource center generating iPSCs, made available to researchers, to benefit the stem cell community in Taiwan and throughout the world.

Advancements in assisted driving technologies are expected to enable future passengers to use a wide range of multimedia applications in electric vehicles (EVs). To address the bandwidth demands for high-resolution and immersive videos during peak traffic, this study introduces a bandwidth-management algorithm to support differentiated streaming services in heterogeneous vehicle-to-everything (V2X) networks. By leveraging cellular 6G base stations, along with Cell-Free (CF) Massive Multi-Input Multi-Output (mMIMO) Wi-Fi 7 access points, the algorithm aims to provide a high-coverage, high-speed, and low-interference V2X network environment. Additionally, Li-Fi technology is employed to supply extra bandwidth to vehicles with limited connectivity via V2V communication. Importantly, the study addresses the urgency and prioritization of different applications to ensure the smooth execution of emergency applications and introduces a pre-downloading mechanism specifically for non-real-time applications. Through simulations, the algorithm's effectiveness in meeting EV users' bandwidth needs for various multimedia streaming applications is demonstrated. During peak-bandwidth-demand periods, users experienced an average increase in bandwidth of 47%. Furthermore, bandwidth utilization across the V2X landscape is significantly improved. [ABSTRACT FROM AUTHOR]

With the rapid advancement of autonomous driving and network technologies, future vehicles will function as network nodes, facilitating information transmission. Concurrently, in-vehicle entertainment systems will undergo substantial enhancements. Beyond traditional broadcasting and video playback, future systems will integrate immersive applications featuring 360-degree views and six degrees of freedom (6DoF) capabilities. As autonomous driving technology matures, vehicle passengers will be able to engage in a broader range of entertainment activities while on the move. However, this evolution in video applications will significantly increase bandwidth demand for vehicular networks, potentially leading to bandwidth shortages in congested traffic areas. This paper presents a method for bandwidth allocation for vehicle video applications within the landscape of vehicle-to-everything (V2X) networks. By utilizing a millimeter-wave (mmWave), terahertz (THz) frequency band, and cell-free (CF) extremely large-scale multiple-input multiple-output (XL-MIMO) wireless communication technologies, we provide vehicle passengers with the necessary bandwidth resources. Additionally, we address bandwidth contention issues in congested road segments by incorporating communication methods tailored to the characteristics of vehicular environments. By classifying users and adjusting according to the unique requirements of various multimedia applications, we ensure that real-time applications receive adequate bandwidth. Simulation experiments validate the proposed method's effectiveness in managing bandwidth allocation for in-vehicle video applications within V2X networks. It increases the available bandwidth during peak hours by 32%, demonstrating its ability to reduce network congestion and ensure smooth playback of various video application types. [ABSTRACT FROM AUTHOR]

ALDH2 gene is coded for the aldehyde dehydrogenase (ALDH), which is an enzyme involved in alcohol metabolism. Compared to normal aldehyde dehydrogenases, a homozygous point mutation on exon 12 from G to A significantly reduces its efficiency. In this study, we have reported the generation of IBMS-iPSC-021-04, IBMS-iPSC-022-01, and IBMS-iPSC-023-03 as induced pluripotent stem cell (iPSC) lines carrying the homozygous form of ALDH2 with the rs671 genetic polymorphism (E487K mutation). These cell lines were characterized in terms of pluripotency and differentiation potential. They serve as useful platforms to study alcohol metabolism and other chronic diseases associated with alcohol consumption.

The ALDH2 mutation (ALDH2*2) is caused by an amino acid substitution ALDH2 rs671 G>A (pE487K) which reduces ALDH2 enzyme activity. When individuals with the ALDH2 mutation consume alcohol, accumulating acetaldehyde in the blood can cause reddened face, headache, nausea, and palpitations; symptoms referred to as Alcohol Flushing Reaction. We report the production of an induced pluripotent stem cell (iPSC) line, FIRDIi001-A, developed from peripheral blood mononuclear cells of a 39-year-old male subject with the ALDH2*2 mutation. The ALDH2-pE487K iPSCs will be valuable in investigating pathogenic mechanisms involved in the link between the ALDH2 polymorphism and alcohol-related diseases.

Sialidosis is a rare autosomal recessive disorder that affects the intralysosomal catabolism of sialylated glycoconjugates and is involved in cellular immune response. Mutations in NEU1, which encodes the sialidase enzyme, result in sialidosis. Sialidosis is characterized by the progressive lysosomal storage of sialylated glycopeptides and oligosaccharides. In this study, we used Sendai virus reprogramming to generate an induced pluripotent stem cell (iPSC) line carrying the A544G mutation combined with the 667-679 deletion of the NEU1 gene from a sialidosis patient. The patient-specific iPSCs expressed pluripotent markers, possessed a normal karyotype, and displayed the capability to differentiate into three germ layers.

Mitochondrial defects are associated with clinical manifestations from common diseases to rare genetic disorders. Myoclonus epilepsy associated with ragged-red fibers (MERRF) syndrome results from an A to G transition at nucleotide position 8344 in the tRNALys gene of mitochondrial DNA (mtDNA) and is characterized by myoclonus, myopathy and severe neurological symptoms. In this study, Sendai reprogramming method was used to generate an iPS cell line carrying the A8344G mutation of mtDNA from a MERRF patient. This patient-specific iPSC line expressed pluripotent stem cell markers, possessed normal karyotype, and displayed the capability to differentiate into mature cells in three germ layers.

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by interactions between genetic and environmental factors. Leucine rich repeat kinase (LRRK2) is the most prevalent mutation in autosomal-dominant inheritance of PD. Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with p.I2012T mutation in LRRK2 gene by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype. The iPSCs also showed pluripotency confirmed by immunofluorescent staining and differentiated into the 3 germ layers in vivo. This cellular model will provide a useful platform for further pathophysiological studies of PD.

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most prevalent monogenic kidney disorder leading to kidney failure. We generated induced pluripotent stem cells (iPSCs) from a 37-year-old man carrying a PKD1 Q533X mutation who suffered from kidney failure and a myocardial infarction. The iPSCs were reprogrammed from the patient's peripheral blood mononuclear cells using the Sendai virus system, and were confirmed to possess the specific PKD1 Q533X mutation and normal karyotype. Pluripotency was confirmed using in vitro and in vivo assays. This iPSC line will be useful for studying the mechanisms driving the complicated pathophysiology of ADPKD.

Leucine rich repeat kinase 2 (LRRK2) is the causative gene for autosomal-dominant familial forms of Parkinson's disease (PD). Here, we generated induced pluripotent stem cells (iPSCs) from the peripheral blood mononuclear cells of a female patient with LRRK2 c.4111A > G (p.I1371V) mutation by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype. The iPSCs also showed pluripotency confirmed by immunofluorescent staining and differentiated into the three germ layers in vivo. This cellular model will provide a platform for studying the role of LRRK2 in the disease process.

A simple, easy, inexpensive, and quick nonsilicon-based micromachining method was developed to manufacture a microlens array. The spherical surface of the microlens was machined using a microshaper mounted on a three-axis vertical computer numerical control (CNC) machine with cutter-path-planning. The results show the machined profiles of microlens agree well with designed profiles. The focus ability of the machined microlens array was verified. The designed and measured focal lengths have average 1.5% error. The results revealed that the focal lengths of micro lens agreed with the designed values. A moderate roughness of microlens surface is obtained by simply polishing. The roughness of the lens surface is 43 nm in feed direction (x-direction) and 56 nm in path interval direction (y-direction). It shows the simple, scalable, and reproducible method to manufacture microlenses by microshaper with cutter-path-planning is feasible.